About Clonmel Healthcare
In 2006 Clonmel Healthcare embarked on a brand redevelopment strategy following the findings of a major customer research report commissioned by the company. In early 2007 the new corporate identity was launched. The new distinctive brand mark represents Clonmel Healthcare’s core values of quality, customer service and dynamism and retains the strength of our heritage and strong link to our Irish roots.
Clonmel Healthcare currently has a large portfolio of products covering three distinct business units; Prescription medicines, Speciality medicines and the ClonMedica Consumer Division. Our prescription products cover a wide range of therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. Within the Special Products Division we have medicines for the treatment of Parkinson’s disease, Testosterone Deficiency Syndrome and the management of diabetes. The ClonMedica product range focuses on three main areas; women’s and babies health, skincare and health supplements.
Clonmel Healthcare is committed to providing less expensive, quality medicines to the Irish market.* This code hides this entire article on the front page *